Concepedia

Hirokazu Kurokawa

HK

14

Publications

1.1K

Citations

13

H-Index

1995

Active since

Affiliations

Nara Medical University(Current)

National Cancer Research Institute

Vanderbilt University

National Cancer Centre Japan

Tokushima University

Hirokazu Kurokawa is an author at Nara Medical University specializing in medicine, tumor biology, and cell biology.

Top concepts

MedicineCell BiologyTumor BiologyCancer ResearchRadiation OncologyCancer BiologyCancer Cell BiologyOncologyLung CancerPharmacology

Publications per year

1995–2004

14

Publications

14

Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.

Hirokazu Kurokawa, Anne E.G. Lenferink, Jean F. Simpson et al. · PubMed · 2000 · 367 citations

Tumor Biology, Breast Oncology, Endocrine-related Cancer +15

Conditional Overexpression of Active Transforming Growth Factor β1 <b> <i>In vivo</i> </b> Accelerates Metastases of Transgenic Mammary Tumors

Rebecca S. Muraoka-Cook, Hirokazu Kurokawa, Yasuhiro Koh et al. · Cancer Research · 2004 · 159 citations · Full text

ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms.

Hirokazu Kurokawa, Carlos L. Arteaga · PubMed · 2003 · 140 citations

Breast Oncology, Human Breast Cancer, Cancer Biology +19

Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.

Hirokazu Kurokawa, Carlos L. Arteaga · PubMed · 2001 · 94 citations

Breast Oncology, Estrogen Receptor, Human Breast Cancer +23

Enhanced interaction between tubulin and microtubule‐associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxel

Kazuto Nishio, Hitoshi Arioka, Tomoyuki Ishida et al. · International Journal of Cancer · 1995 · 54 citations

Rows per page

1–5 of 14